Tatlock, Sophi
Sully, Kate
Batish, Anjali https://orcid.org/0000-0002-1008-9710
Finbow, Chelsea https://orcid.org/0000-0001-6926-1872
Neill, William
Lines, Carol
Brennan, Roisin
Adlard, Nicholas https://orcid.org/0000-0001-6912-1685
Backhouse, Tamara https://orcid.org/0000-0001-8194-4174
Funding for this research was provided by:
Novartis Pharma
Article History
Accepted: 30 January 2023
First Online: 5 April 2023
Declarations
:
: The research was conducted by Adelphi Values Patient-Centered Outcomes who received funding from Novartis Pharma AG to complete this work. Some of the authors are salaried employees of Novartis Pharma AG.
: The research was conducted by Adelphi Values Patient-Centered Outcomes who received funding from Novartis Pharma AG to complete this work.
: The study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by Western Independent Review Board® (WIRB).
: Informed consent was obtained from all individual participants included in the study.
: Participants signed informed consent regarding publishing their anonymized data.
: All data generated or analyzed during this study are included in this published article (and its supplementary information files). The data that support the findings of this study are available from Novartis, but restrictions apply to the availability of these data, which were used under licence for the current study and so are not publicly available.The data are, however, available from the authors upon reasonable request and with the permission of Novartis.
: Not applicable.
: Adelphi Values authors (AB, ST, KS, WN and CF) contributed to the study design, data collection, interpretation of data, and preparation of the manuscript for publication. All other authors (CL, RB, NA and TB) contributed to defining the scope of the research, including study design; and interpretation of study results in the manuscript. All authors reviewed and approved this manuscript.